Breaking News on Drug Discovery |
All news articles > April 2003
| « Previous month | Next month » |
25-Apr-2003
The new face of genomics
Prominent US genomics Robert L. Strausberg, who directs the National Cancer Institute's (NCI) Cancer Genomics office, has been named as vice president for research at...
17-Apr-2003
Trimming the costs, IBM in drug discovery collaboration
IBM in the UK and US based IDBS, a provider of data management, analysis and decision-making software for drug discovery, this week announced a global...
Phytochemical collaboration
Canadian drug discovery company Phytobiotech has entered into an agreement to supply Achillion Pharmaceuticals with purified, plant derived small molecules (phytochemicals) from its PurePhytoLib library....
16-Apr-2003
Scientific progress and property rights, the right balance
An expert group on intellectual property rights (IPRs) has warned that rules governing the protection of copyrights, database rights and patents hamper scientific endeavour and...
LION: improving drug discovery
LION bioscience this week launched the latest version of its open integration platform, LION DiscoveryCenter 3.2, with an enhanced chemistry functionality for integrated drug discovery....
Strong growth for protein array technology sales
Total revenues for the four emerging sectors of protein array, crucial antibody array, peptide biochip, protein biochip, and solution bead/particle array were estimated at $90...
14-Apr-2003
Celltech lays claims to OGS
UK biotechnology bellwether Celltech has emerged victorious in the bidding battle for Oxford GlycoSciences. OGS reluctantly gave in to Celltech's pressure on April 11, after...
Human genome project clears final hurdle
Researchers have now completed the sequencing of the human genome, to an accuracy of 99.999 per cent, nearly three years after the first 'working' draft...
11-Apr-2003
PerkinElmer wins analytical award
US company PerkinElmer was presented with the 2003 Analytical Instrumentation Company of the Year award by market research company Frost & Sullivan in a ceremony...
New amplification kit from Amersham
Amersham Biosciences has launched a new DNA Amplification Kit, GenomiPhi, which it says can simplify the DNA preparation process and enable high-quality DNA to be...
09-Apr-2003
Berlex buys CompleGen system
Genetics-based drug discovery company CompleGen is to supply Berlex Biosciences, a US affiliate of German company Schering, with a high throughput assay system for discovery...
deCODE sells crystallography platform
Iceland-based deCODE genetics announced this week that AstraZeneca has entered into an agreement to purchase its RoboHTC automated protein crystallography platform, earmarked for AstraZeneca's drug...
02-Apr-2003
Gennaissance buys battered DNA Sci
Drug discovery company Genaissance Pharmaceuticals is to acquire bankrupt applied genetics company DNA Sciences for $1.3 million (€1.2 m) in cash. Under terms of the...
| « Previous month | Next month » |
© 2000/2009 - Decision News Media SAS - All right reserved.
